Using the kinases chosen through feature selection and shown in Figure 4C, we evaluated the ability to use MIB-binding profiles to define subtypes of human HER2+ needle biopsies and TNBC breast tumors (Figure 4D and 4E). The gene discussed is ERBB2; the disease is breast neoplasm.